Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Public Citizen Agrees With AMA On (Drug) Liability, Petitions FDA On Generic Labeling

This article was originally published in The Pink Sheet Daily

Executive Summary

The consumer watchdog group asks that ANDA holders be able to file a supplemental label change through the changes-being-effected procedure.
Advertisement

Related Content

Generic Firms Get Supreme Shield From Product Liability, But Court Hints At Reg Change
Generic Firms Get Supreme Shield From Product Liability, But Court Hints At Reg Change

Topics

Advertisement
UsernamePublicRestriction

Register

PS072703

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel